These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11407828)

  • 1. Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
    Mian R; Henderson MA; Speakman D; Finkelde D; Ainslie J; McKenzie A
    Can J Surg; 2001 Jun; 44(3):189-92. PubMed ID: 11407828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
    Kam PC; Thompson JF
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1039-45. PubMed ID: 20604735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
    Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
    Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Melanoma Res; 2009 Apr; 19(2):106-11. PubMed ID: 19282789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
    Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha.
    Deroose JP; Eggermont AM; van Geel AN; Verhoef C
    Curr Opin Oncol; 2011 Mar; 23(2):183-8. PubMed ID: 21150602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an automated circuit for isolated limb infusion for malignancy.
    Grobmyer SR; Filichia L; Robinson AR; Clark TD; Vaughn K; Copeland EM; Hochwald SN
    Eur J Surg Oncol; 2010 Dec; 36(12):1215-9. PubMed ID: 20947288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
    Beasley GM; Caudle A; Petersen RP; McMahon NS; Padussis J; Mosca PJ; Zager JS; Hochwald SN; Grobmyer SR; Delman KA; Andtbacka RH; Noyes RD; Kane JM; Seigler H; Pruitt SK; Ross MI; Tyler DS
    J Am Coll Surg; 2009 May; 208(5):706-15; discussion 715-7. PubMed ID: 19476821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does increased experience with isolated limb infusion for advanced limb melanoma influence outcome? A comparison of two treatment periods at a single institution.
    Huismans AM; Kroon HM; Kam PC; Thompson JF
    Ann Surg Oncol; 2011 Jul; 18(7):1877-83. PubMed ID: 21499810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
    Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
    J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
    Testori A; Verhoef C; Kroon HM; Pennacchioli E; Faries MB; Eggermont AM; Thompson JF
    J Surg Oncol; 2011 Sep; 104(4):397-404. PubMed ID: 21858835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
    Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
    Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Carr M; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Tyler DS; Coventry BJ; Zager JS; Thompson JF
    Ann Surg Oncol; 2020 May; 27(5):1420-1429. PubMed ID: 32152775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life outcomes after isolated limb infusion.
    McClaine RJ; Giglia JS; Ahmad SA; McCoy SJ; Sussman JJ
    Ann Surg Oncol; 2012 May; 19(5):1373-8. PubMed ID: 22302268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.